High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$69.7M
$69,650,457
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Sell to Cover
|
2026-03-06 | $212,083 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $17,506 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $34,935 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $34,825 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $69,472 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $50,176 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $51,708 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $17,183 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $68,639 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $34,228 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $179,283 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-03-06 | $17,003 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-06 | $279,033 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-06 | $718,316 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Kelley Shannon T
• Officer • General Counsel
Sell to Cover
2026-03-06
$155,498
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Officer • General Counsel
Sell to Cover
|
2026-03-06 | $155,498 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Huntsman Carole
• Officer • Chief Commercial Officer
Sell to Cover
2026-03-06
$180,983
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-03-06 | $180,983 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
Sell to CoverΔOwn -11.3%
|
2026-03-02 | $505,389 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Other
|
2026-02-23 | $18,400 | M | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-26 | $776,546 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Other
|
2026-01-26 | $65,840 | M | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Huntsman Carole
• Officer • Chief Commercial Officer
10b5-1 Sell
2026-01-26
$281,916
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Officer • Chief Commercial Officer
10b5-1 Sell
|
2026-01-26 | $281,916 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Huntsman Carole
• Officer • Chief Commercial Officer
Sell to Cover
2026-01-26
$167,423
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-01-26 | $167,423 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Sell to Cover
|
2026-01-26 | $318,596 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Kelley Shannon T
• Officer • General Counsel
Sell to Cover
2026-01-20
$129,073
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Officer • General Counsel
Sell to Cover
|
2026-01-20 | $129,073 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Kelley Shannon T
• Officer • General Counsel
10b5-1 Sell
2026-01-20
$215,101
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Officer • General Counsel
10b5-1 Sell
|
2026-01-20 | $215,101 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Taub Rebecca
• Director
Sell to Cover
2026-01-20
$1,098,343Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Sell to Cover
|
2026-01-20 | $1,098,343Large | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $160,205 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Other
|
2026-01-09 | $290,878 | M | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $491,537 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $492,595 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $482,207 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $813,968 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $269,257 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Taub Rebecca
• Director
10b5-1 Sell
2026-01-09
$1,058,468Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $1,058,468Large | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $503,106 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $280,220 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $229,289 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $306,909 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $382,823 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $699,623 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $781,903 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $480,281 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $598,091 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $245,593 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $293,222 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $135,796 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $15,931 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $21,300 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $144,761 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $47,609 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $206,700 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $21,514 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $215,706 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $21,610 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $217,088 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Other
|
2026-01-09 | $3,792 | M | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $21,832 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $110,248 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Other
|
2026-01-09 | $387,416 | M | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $757,727 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $561,340 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $692,246 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
FRIEDMAN PAUL A
• Director
10b5-1 Sell
2026-01-09
$1,029,561Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $1,029,561Large | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $395,896 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
FRIEDMAN PAUL A
• Director
10b5-1 Sell
2026-01-09
$1,268,755Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $1,268,755Large | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $706,966 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $439,822 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $354,823 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $438,461 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $507,307 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $628,394 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
FRIEDMAN PAUL A
• Director
10b5-1 Sell
2026-01-09
$1,276,916Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $1,276,916Large | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $560,717 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $822,071 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $303,702 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $365,653 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $87,941 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $148,592 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $42,600 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $177,342 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $79,223 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $253,538 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $261,459 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $43,028 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $258,831 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $324,215 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $21,832 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Other
|
2026-01-09 | $4,424 | M | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $154,348 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Equity Compensation
|
2025-12-10 | $0 | M | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $111,078 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $569,822 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Taub Rebecca
• Director
10b5-1 Sell
2025-12-10
$1,709,826Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $1,709,826Large | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Taub Rebecca
• Director
10b5-1 Sell
2025-12-10
$2,132,197Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $2,132,197Large | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Taub Rebecca
• Director
10b5-1 Sell
2025-12-10
$2,433,641Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $2,433,641Large | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Taub Rebecca
• Director
10b5-1 Sell
2025-12-10
$2,602,307Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $2,602,307Large | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $267,335 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $202,418 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $268,949 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Equity Compensation
|
2025-12-10 | $0 | M | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $341,794 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Other
|
2025-12-10 | $391,840 | M | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
FRIEDMAN PAUL A
• Director
10b5-1 Sell
2025-12-10
$2,377,826Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $2,377,826Large | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Other
|
2025-12-10 | $294,670 | M | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
FRIEDMAN PAUL A
• Director
10b5-1 Sell
2025-12-10
$3,968,129Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $3,968,129Large | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
FRIEDMAN PAUL A
• Director
10b5-1 Sell
2025-12-10
$3,058,332Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $3,058,332Large | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
FRIEDMAN PAUL A
• Director
10b5-1 Sell
2025-12-10
$2,769,728Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $2,769,728Large | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $571,091 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $88,862 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $224,945 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $293,451 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Sibold William John
• CEO
Sell to Cover
2025-12-04
$1,380,816Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-12-04 | $1,380,816Large | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CEO
Equity Compensation
|
2025-12-03 | $0 | M | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $234,516 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $202,847 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $411,559 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $68,994 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $138,276 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $184,901 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $149,338 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $278,329 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $140,505 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $141,084 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $94,344 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $94,460 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $44,045 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $47,695 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
Equity Compensation
|
2025-12-02 | $0 | M | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2025-12-02 | $182,524 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
CFO
Other
|
2025-12-02 | $1,050,052Large | M | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Huntsman Carole
• Officer • Chief Commercial Officer
10b5-1 Sell
2025-11-21
$22,528
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Officer • Chief Commercial Officer
10b5-1 Sell
|
2025-11-21 | $22,528 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Huntsman Carole
• Officer • Chief Commercial Officer
10b5-1 Sell
2025-11-21
$45,165
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Officer • Chief Commercial Officer
10b5-1 Sell
|
2025-11-21 | $45,165 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Huntsman Carole
• Officer • Chief Commercial Officer
Sell to Cover
2025-11-21
$492,567
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2025-11-21 | $492,567 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Huntsman Carole
• Officer • Chief Commercial Officer
10b5-1 Sell
2025-11-21
$78,807
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Officer • Chief Commercial Officer
10b5-1 Sell
|
2025-11-21 | $78,807 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Huntsman Carole
• Officer • Chief Commercial Officer
10b5-1 Sell
2025-11-21
$65,845
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Officer • Chief Commercial Officer
10b5-1 Sell
|
2025-11-21 | $65,845 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Huntsman Carole
• Officer • Chief Commercial Officer
10b5-1 Sell
2025-11-21
$21,974
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Officer • Chief Commercial Officer
10b5-1 Sell
|
2025-11-21 | $21,974 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Huntsman Carole
• Officer • Chief Commercial Officer
10b5-1 Sell
2025-11-21
$110,477
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Officer • Chief Commercial Officer
10b5-1 Sell
|
2025-11-21 | $110,477 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Huntsman Carole
• Officer • Chief Commercial Officer
10b5-1 Sell
2025-11-21
$22,129
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Officer • Chief Commercial Officer
10b5-1 Sell
|
2025-11-21 | $22,129 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Huntsman Carole
• Officer • Chief Commercial Officer
10b5-1 Sell
2025-11-21
$66,725
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Officer • Chief Commercial Officer
10b5-1 Sell
|
2025-11-21 | $66,725 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Huntsman Carole
• Officer • Chief Commercial Officer
10b5-1 Sell
2025-11-21
$111,920
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Officer • Chief Commercial Officer
10b5-1 Sell
|
2025-11-21 | $111,920 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Huntsman Carole
• Officer • Chief Commercial Officer
10b5-1 Sell
2025-11-21
$44,850
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Officer • Chief Commercial Officer
10b5-1 Sell
|
2025-11-21 | $44,850 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-11-13 | $80,247 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Other
|
2025-11-13 | $98,760 | M | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-11-13 | $75,142 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-11-13 | $473,876 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-11-13 | $333,796 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-11-13 | $432,974 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-11-13 | $704,147 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-11-13 | $160,369 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-11-13 | $570,836 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-11-13 | $749,557 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-11-13 | $424,687 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-11-13 | $63,202 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-11-13 | $105,570 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-11-13 | $232,586 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-11-13 | $21,208 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Other
|
2025-11-13 | $18,400 | M | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Discretionary Sell
|
2025-11-05 | $14,729 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
BATE KENNETH
• Director
Discretionary Sell
2025-11-05
$846,663
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Discretionary Sell
|
2025-11-05 | $846,663 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Other
|
2025-11-05 | $309,444 | M | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
BATE KENNETH
• Director
Discretionary SellΔOwn -39.3%
2025-11-05
$1,352,796Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Discretionary SellΔOwn -39.3%
|
2025-11-05 | $1,352,796Large | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
BATE KENNETH
• Director
Discretionary SellΔOwn -10.5%
2025-11-05
$402,530
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Discretionary SellΔOwn -10.5%
|
2025-11-05 | $402,530 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
BATE KENNETH
• Director
Discretionary SellΔOwn -16.2%
2025-11-05
$340,409
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Discretionary SellΔOwn -16.2%
|
2025-11-05 | $340,409 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
BATE KENNETH
• Director
Discretionary SellΔOwn -11.3%
2025-11-05
$489,421
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Discretionary SellΔOwn -11.3%
|
2025-11-05 | $489,421 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Other
|
2025-11-05 | $3,037,900Large | M | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Other
|
2025-11-05 | $51,691 | M | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
BATE KENNETH
• Director
Discretionary SellΔOwn -17.8%
2025-11-05
$936,105
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Discretionary SellΔOwn -17.8%
|
2025-11-05 | $936,105 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
BATE KENNETH
• Director
Discretionary SellΔOwn -16.0%
2025-11-05
$1,000,170Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Discretionary SellΔOwn -16.0%
|
2025-11-05 | $1,000,170Large | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
BATE KENNETH
• Director
Discretionary Sell
2025-11-05
$619,417
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Discretionary Sell
|
2025-11-05 | $619,417 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
BATE KENNETH
• Director
Discretionary SellΔOwn -18.7%
2025-11-05
$1,567,995Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Discretionary SellΔOwn -18.7%
|
2025-11-05 | $1,567,995Large | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
BATE KENNETH
• Director
Discretionary SellΔOwn -26.0%
2025-11-05
$457,119
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Discretionary SellΔOwn -26.0%
|
2025-11-05 | $457,119 | S | Form 4 |